Company Analysis

Geron Corporation (GERN)

Nasdaq: GERN · Pharmaceutical Preparations · Foster City, CA · filing with the SEC since 1996
Grade3.5
◀ Past 4.3● Present 3.5▶ Future 3.1
2 est.

Who runs Geron Corporation

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Bir Dawn Carter
Interim President and CEO. First filing Mar 2019, latest May 26, 2026, 0 filings in all.
Officers reporting now
6
of 12 people with a filing in the last fifteen months
Directors reporting now
6
27 people on the record since 2006
Officerssales are open-market, Oct 1, 2025 to Oct 1, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Bir Dawn CarterInterim President and CEOMar 2019May 26, 2026none
Williams TimothyEVP and Chief Legal OfficerApr 2026Apr 14, 2026none
Robertson MichelleEVP, CHIEF FINANCIAL OFFICERSep 2023Feb 19, 20261 · $0.00
Eid JosephEVP, R&D; Chief Medical OfficeNov 2024Feb 19, 2026none
Elnawawi AhmedEVP, Chief Commercial OfficerOct 2025Oct 20, 2025none
Semerjian HaroutPresident and CEOAug 2025Aug 8, 2025none
Directorssales are open-market, Oct 1, 2025 to Oct 1, 2026
NameRoleFirst filingLatest filingSales, 12 months
Spiegel Robert J.directorMay 2010Oct 1, 2026none
Mcdonald John FdirectorSep 2022May 26, 2026none
Molineaux SusandirectorSep 2012May 26, 2026none
O'Farrell Elizabeth G.directorMar 2019May 26, 2026none
Andrews Patricia SdirectorMar 2026Mar 26, 2026none
Chinoporos ConstantinedirectorMar 2026Mar 26, 2026none
Earlier names on the record15, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton GERN · research, not advice